Benchtop Spectroradiometer System with Flexible Microscope Probes and SDK
FDA · FOOD AND DRUG ADMINISTRATION
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation CDRH-OSEL-26-C-D718 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
This is a combined synopsis/solicitation for commercial products prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested, and a separate written solicitation will not be issued. The solicitation number is CDRH-OSEL-26-C-D718, issued as a Request for Quotations (RFQ). The U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), requires a high-precisio… (show all)
n benchtop spectroradiometer system for acquiring spectral data from a microscope: (1) a benchtop spectroradiometer (wavelength range at least 380-780 nm, back-thinned cooled CCD with at least 512 elements, spectral bandwidth under 5 nm, wavelength accuracy under 0.5 nm, variable internal apertures of 2, 1, and 0.1-0.25 degrees); (2) flexible probes (4 ft or longer) for luminance/radiance measurement of a light microscope; and (3) a fully documented Software Development Kit with command-line control (Python/MATLAB) and raw-data export, compatible with Windows 10 or later. Full salient characteristics are in the attached Statement of Work. Equipment shall be new and non-refurbished, calibrated prior to delivery with certificate, with a minimum 1-year warranty. This acquisition is unrestricted (full and open competition) under FAR Parts 12 and 13; NAICS 423450 (size standard 200 employees); PSC 6650. A single firm-fixed-price purchase order will be awarded on a Lowest-Priced Technically Acceptable (LPTA) basis. Delivery is required within 60 days after award, FOB Destination, Silver Spring, MD. Vendor questions are due July 24, 2026, 12:00 PM ET by email. Quotes are due July 29, 2026, 12:00 PM ET by email to james.jenretteiii@fda.hhs.gov. Quotes shall include itemized all-inclusive pricing for CLINs 0001-0003 (any tariff/surcharge identified separately), a point-by-point statement of compliance against the SOW salient characteristics with supporting literature, delivery confirmation, warranty and recalibration-support terms, UEI/CAGE/business size, and 60-day quote validity. Quoters must be actively registered in SAM.gov. FAR 52.212-1, 52.212-3, 52.212-4, and 52.212-5 apply. See the attached combined synopsis/solicitation document and Statement of Work for full terms.
Who won similar work
24 award notices on SAM.gov in the last 24 months. Match: Same agency (FDA), any industry: a loose match.
Loose match: same agency, any industry. Read the titles before treating these as competitors.
| Winner | Awards | Value | Last |
|---|---|---|---|
| Please_See_Spreadsheet Silver Spring MD 20993 USA | 3 | $153.2M | Oct 8, 2026 |
| DCT, INCORPORATED | 1 | $52.8M | Sep 15, 2026 |
| TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC | 1 | $50.0M | Sep 16, 2025 |
| NATI-NVE Support Services, LLC | 1 | $49.0M | May 21, 2026 |
| HARVARD PILGRIM HEALTH CARE INC | 1 | $31.7M | Mar 30, 2026 |
| TOXICOLOGIC PATHOLOGY ASSOCIATES INC | 1 | $26.1M | Sep 15, 2025 |
| IHRC, INCORPORATED | 1 | $14.5M | Sep 16, 2026 |
| VITALANT Scottsdale AZ 85258 USA | 1 | $10.0M | Sep 8, 2025 |
| WE PHARMA, INC. | 1 | $4.0M | Sep 11, 2026 |
| THE BIONETICS CORP | 1 | $2.8M | Jul 21, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Oct 8, 2026Please_See_Spreadsheet Silver Spring MD 20993 USA$120.8MFY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
- Sep 24, 2026TRADESPACE INC$82KPlatform Subscription to Support Transfer Program Commercial Assessment Leads
- Sep 24, 2026TURBOFIL PACKAGING MACHINES, LLC$454KAutomated Vial Capper Machine and Labeler system
- Sep 22, 2026ABIDE INTERNATIONAL, INC.$1.8MBuilding Exterior Repair Project � FDA Pacific Southwest Laboratory
- Sep 17, 2026LUSARDI CONSTRUCTION CO. San Marcos CA 92078 USA$779KIRV Exhaust and Vacuum Pump Replacement
- Sep 16, 2026IHRC, INCORPORATED$14.5MFDA Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) IDIQ
- Sep 15, 2026DCT, INCORPORATED$52.8MNational Center for Toxicological Research (NCTR) on-site facility Operations and Maintenance (O&M) support services
- Sep 11, 2026WE PHARMA, INC.$4.0MPharmaceutical Products for CDER Research Studies - IDIQ
- Aug 31, 2026GOVERNMENT SCIENTIFIC SOURCE INC$399KDigital Slide Scanner System
- Aug 21, 2026Z-SPEC, INC.$123KPost-Award Public Notice
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Food & Drug Administration (FDA) since 2024 (0 filings)
- 0 of their lobbyists list a past Food & Drug Administration (FDA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 129 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.